Aptose Biosciences
APTO
#10465
Rank
S$5.66 M
Marketcap
S$2.22
Share price
0.00%
Change (1 day)
727.28%
Change (1 year)

Aptose Biosciences (APTO) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : S$19.28 Million

According to Aptose Biosciences's latest financial reports the company's total liabilities are S$19.28 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aptose Biosciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$20.98 M17.82%
2022-12-31S$17.81 M58.94%
2021-12-31S$11.2 M15.29%
2020-12-31S$9.71 M10.07%
2019-12-31S$8.83 M131.76%
2018-12-31S$3.81 M61.4%
2017-12-31S$2.36 M23.76%
2016-12-31S$1.9 M-20.77%
2015-12-31S$2.4 M
2014-05-31S$2.84 M28.32%
2013-05-31S$2.21 M-34.22%
2012-05-31S$3.36 M130.44%
2011-05-31S$1.46 M-61.6%
2010-05-31S$3.8 M-81.87%
2009-05-31S$20.99 M-0.82%
2008-05-31S$21.16 M3.14%
2007-05-31S$20.52 M1.97%
2006-05-31S$20.12 M5.24%
2005-05-31S$19.12 M162.37%
2004-05-31S$7.28 M8.1%
2003-05-31S$6.74 M68%
2002-05-31S$4.01 M-41.86%
2001-05-31S$6.9 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Advaxis
ADXS
S$53.2 M 175.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
S$18.28 M-5.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
S$0.33 B 1,653.06%๐Ÿ‡บ๐Ÿ‡ธ USA